Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh
Open Access
- 9 September 2023
- journal article
- research article
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 16 (11) , 1716-1721
Abstract
No abstract availableKeywords
Funding Information
- WHO TDR
- World Health Organization (P20-00141)
This publication has 11 references indexed in Scilit:
- Measures, Gaps, and Mitigation Strategies in Bangladesh’s COVID-19 ResponseEcohealth, 2022
- COVID-19 Pandemic Causes Increased Clinic Visits with Diagnosis of Tegumentary Leishmaniasis in Brazil in 2020International Journal of Infectious Diseases, 2021
- Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2021
- Neglected tropical disease control in a world with COVID-19: an opportunity and a necessity for innovationTransactions of the Royal Society of Tropical Medicine and Hygiene, 2020
- Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for InnovationClinical Infectious Diseases, 2020
- Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from BangladeshPLOS Neglected Tropical Diseases, 2019
- Eliminating visceral leishmaniasis in South Asia: the road aheadBMJ, 2019
- Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand FliesClinical Infectious Diseases, 2018
- Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.PLOS Neglected Tropical Diseases, 2017
- Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of BangladeshPLOS Neglected Tropical Diseases, 2010